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Although risk factors for primary cutaneous melanoma are well defined, relatively little is known about
predictors for second primary melanoma. Given the rising incidence of this cancer, coupled with improvements
in survival, there is a prevalent and growing pool of patients at risk of second primary melanomas. To identify
the predictors of second primary melanoma, we followed a cohort of 1,083 Queensland patients diagnosed with
incident melanoma between 1982 and 1990 and who completed a baseline questionnaire. During a median
follow-up of 16.5 years, 221 patients were diagnosed with at least one additional primary melanoma. In
multivariate analyses, second primary melanomas were associated with high nevus count (hazard ratio (HR),
2.91; 95% confidence interval (CI) 1.94–4.35), high familial melanoma risk (HR, 2.12; 95% CI 1.34–3.36), fair skin
(HR, 1.51; 95% CI 1.06–2.16), inability to tan (HR, 1.66; 95% CI 1.13–2.43), an in situ first primary melanoma (HR,
1.36; 95% CI 0.99–1.87), and male sex (HR, 1.49; 95% CI 1.12–2.00). Patients whose first primary was lentigo maligna
melanoma (HR, 1.80; 95% CI 1.05–3.07) or nodular melanoma (HR, 2.13; 95% CI 1.21–3.74) had higher risks of
subsequent primaries than patients whose first primary tumor was superficial spreading melanoma. These
characteristics could be assessed in patients presenting with first primary melanoma to evaluate risk of
developing a second primary.
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INTRODUCTION
During the past several decades, there have been marked
increases in the incidence of cutaneous melanoma in fair-
skinned populations around the world, particularly for thin
melanomas (Garbe et al., 2000; Jemal et al., 2001; de Vries
et al., 2003; Coory et al., 2006; MacKie et al., 2007).
Whereas for previous generations, a diagnosis of melanoma
carried a grim prognosis, the majority of melanoma patients
diagnosed today can expect to survive their disease. How-
ever, the improved survival rates coupled with population-
wide increases in life expectancy mean that the risk of
developing a subsequent melanoma will inevitably rise. This
poses clinical challenges, for while guidelines exist to treat
cutaneous melanoma and to manage recurrence, little
attention has been paid to manage the risk of subsequent
invasive melanoma.
Registry-based linkage studies suggest that the cumulative
incidence of second primary melanomas varies across
populations, estimated at 1.5% at 10 years in Switzerland
(Levi et al., 2005), 5.3% in the United States; (Goggins and
Tsao, 2003), and 6.4% in Queensland, Australia (McCaul
et al., 2008). More detailed analyses of registry and clinical
case series show that the risk of subsequent melanoma is
highest in the first year following initial diagnosis (Goggins and
Tsao, 2003; Ferrone et al., 2005; McCaul et al., 2008), and that
the annual rate of new diagnoses of primary melanoma
appears to be relatively constant thereafter (McCaul et al.,
2008). Most studies, but not all, indicate that the risk of
subsequent melanoma increases with the age at which the first
melanoma was diagnosed, but that sex and anatomic site do
not appear to influence the risk of subsequent lesions (Goggins
and Tsao, 2003; McCaul et al., 2008).
Phenotypic or other host factors that could be ascertained
in the clinic and which might predict future risk of
subsequent melanomas have been examined only in two
prospective studies (Ferrone et al., 2005; Titus-Ernstoff et al.,
2006) from which some consistent features have emerged.
A verified family history of melanoma and the presence of
either very large numbers of banal nevi or at least one
atypical nevus have been associated with increased risks of
subsequent melanomas in both studies. Evidence for a role of
pigmentary characteristics (such as freckling, hair color, and
skin type) that are strongly associated with the risk of
developing primary melanoma is inconsistent owing to the
paucity of data.
In this study, we document the distribution of second
and subsequent melanomas in a large prospective cohort of
Queensland patients diagnosed with primary cutaneous
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melanoma, and identify the factors associated with their
development.
RESULTS
The age and sex distribution of the 1,083 probands in the
Queensland Familial Melanoma Project (QFMP) follow-up
study are given in Table 1. There were 27% more women
than men, and the latter were on average almost 4 years older
(47.8 years among men, 43.9 among women). Only two
probands were related to one another. The mean interval
from index diagnosis to follow-up contact was 16.8 years
(median 16.5 years) with a range of 12.3–23.0 years. There
was little variation in this respect between men and women
or by age.
Occurrence and characteristics of second primary melanomas
There were 221 persons in the subcohort with at least one
primary melanoma other than the index lesion and a total of
375 such lesions (118 in situ and 257 invasive). Among these,
the index melanoma was in situ or invasive in 63 and 158
persons, respectively. Excluding those with only synchronous
melanomas reduced these numbers to 208 individuals
(61 with in situ and 147 with invasive index melanomas)
with at least one subsequent metachronous primary melano-
ma and 362 lesions (116 in situ and 246 invasive). The 158
individuals with invasive index lesions had 152 invasive and
105 in situ additional melanomas. In total, more than 20% of
the overall sample had more than one primary melanoma,
and one individual had nine (Table 2).
Compared with those with in situ index lesions, partici-
pants whose first primary melanoma was invasive (Clark level
2 or greater) were somewhat more likely to have inva-
sive second melanomas but the difference was not statis-
tically significant (Table 3). There was little difference in
mean and median thickness from index to second metachro-
nous melanoma (index melanoma: mean 0.82±0.03mm,
median 0.55mm; second metachronous melanoma: mean
0.85±0.09mm, median 0.55mm). There was only weak
evidence of specific anatomical concordance between the
body site of the index and second metachronous primary
melanomas (unweighted k 0.21) although the association was
highly significant (Table 3).
Table 1. Distribution by sex of characteristics of
participants (probands) in the QFMP follow-up study
Males (N=477) Females (N=606) Total (N=1,083)
N (%) N (%) N (%)
Age (years)
o40 135 (28.3) 245 (40.4) 380 (35.1)
40–49 122 (25.6) 154 (25.4) 276 (25.5)
50–59 123 (25.8) 122 (20.1) 245 (22.6)
X60 97 (20.3 85 (14.0) 182 (16.8)
Site1
Head/neck 66 (13.8) 56 (9.2) 122 (11.3)
Trunk 217 (45.5) 133 (22.0) 350 (32.3)
Upper limbs 92 (19.3) 157 (25.9) 249 (23.0)
Lower limbs 72 (15.1) 237 (39.1) 309 (28.5)
Unspecified 30 (6.3) 23 (3.8) 53 (4.9)
Clark level1
1 110 (23.1) 136 (22.4) 246 (22.7)
2 191 (40.0) 256 (42.2) 447 (41.3)
3 85 (17.8) 110 (18.2) 195 (18.0)
4/5 52 (10.9) 64 (10.6) 116 (10.7)
Missing 39 (8.2) 40 (6.6) 79 (7.3)
Familial risk group
High 30 (6.3) 33 (5.4) 63 (5.8)
Intermediate 109 (22.8) 170 (28.1 279 (25.8)
Low 338 (70.9) 403 (66.5) 741 (68.4)
Morphology1
Nodular 29 (6.1) 30 (5.0) 59 (5.4)
SSM 318 (66.7) 435 (71.8) 753 (69.5)
LMM 26 (5.4) 28 (4.6) 54 (5.0)
NOS 104 (21.8) 113 (18.6) 217 (20.0)
Abbreviations: LMM, lentigo maligna melanoma; NOS, not otherwise
specified; SSM, superficial spreading melanoma.
1Tumor-specific characteristics relate to the first primary melanoma.
Table 2. Number of persons with at least one
synchronous melanoma and by number of
metachronous melanomas by behavior of index
melanoma
In situ Invasive Total
N (%) N (%) N (%)
Number of additional melanomas
0 199 (76.0) 663 (80.8) 862 (79.6)
Synchronous melanomas only
2 (0.8) 11 (1.3) 13 (1.2)
Metachronous melanomas
1 33 (12.6) 93 (11.3) 126 (11.6)
2 14 (5.3) 28 (3.4) 42 (3.9)
3 8 (3.1) 13 (1.6) 21 (1.9)
4 3 (1.1) 7 (0.9) 10 (0.9)
5 2 (0.8) 6 (0.7) 8 (0.7)
X6 1 (0.4) 0 (0.0) 1 (0.1)
Total 262 821 1083
462 Journal of Investigative Dermatology (2011), Volume 131
V Siskind et al.
Risk Factors for Primary Cutaneous Melanoma
Predictors of multiple primary melanomas: univariate analyses
Mean numbers of subsequent melanomas increased by age
overall and in women, whereas in men the only major
difference was between those under 40 years of age and
those in older age groups (Table 4). Sex, age, morphology,
familial risk, numbers of nevi, red phenotype, skin color, skin
type, tanning ability, and a history of solar keratoses or non-
melanoma skin cancers were all significantly related to
numbers of subsequent primary melanomas, some highly
significantly; invasive behavior showed a marginal associa-
tion (Table 4). Associations were generally weaker in women.
We found no overall association between numbers of
subsequent primary melanomas and any of anatomic site,
freckling, Clark level, history of sunburns, and hair or
eye color. Findings from failure-time analyses of time to
first metachronous primary melanoma were broadly
similar, except that the association with invasive behavior
was stronger.
Of 40 individuals with at least four primary melanomas,
11 were from the high-risk group, almost five times expec-
tation assuming no association between familial history and
risk of multiple primaries, whereas 18 were from the low-risk
group, 30% less than expectation.
We observed no association between time to second
metachronous primary and either the thickness of index
melanoma or with continuous measures of UV exposure in
childhood, adolescence, or adulthood (data not shown). All
nonparametric correlations were small, between 0.05 and
0.04, and nonsignificant (data not shown).
Predictors of second primary melanomas: multivariate analyses
Probands with a large number of nevi, those in the familial
high-risk group or whose index melanoma was nodular had
significant 2-fold and greater increased risks for subsequent
primary melanomas. Men, individuals with a moderate
number of nevi, whose index melanoma was an lentigo
maligna melanoma or in situ or who had fair skin or an
inability to tan were also at elevated risk of acquiring a
second primary lesion (Table 5). We repeated the analysis by
Table 3. Behavior and anatomic site of index melanomas versus metachronous second primary melanomas
Index melanoma In situ (N) In situ (%) Invasive (N) Invasive (%) Total (N) Total1 (%)
In situ 34 55.7 27 44.3 61 29.3
Invasive 64 43.5 83 56.5 147 70.7
Total 98 47.1 110 52.9 208 100
Index melanoma Head/neck, N (%) Trunk, N (%) Upper limb,
N (%)
Lower limb, N (%) Total (N) Total2 (%)
Head/neck 15 (50.0) 5 (16.7) 6 (20.0) 5 (16.7) 31 14.9
Trunk 10 (15.4) 28 (44.6) 14 (21.5) 12 (18.5) 64 32.2
Upper limb 15 (30.0) 13 (26.0) 15 (30.0) 7 (14.0) 50 24.8
Lower limb 7 (12.3) 10 (17.5) 15 (26.3) 25 (43.9) 57 28.2
Total 47 (23.3) 56 (27.7) 50 (24.7) 49 (24.3) 202 100
1Six index melanomas and second metachronous melanomas did not have anatomical site recorded.
2Totals do not sum to 100% due to rounding.
Table 4. Nonparametric (Kruskal–Wallis) analysis of
variance of numbers of melanomas (excluding index
primary)
Males Females All
Factor d.f. v2 P v2 P v2 P
Sex 1 8.67 0.003
Age category 3 23.9 o0.001 1.69 0.64 20.8 o0.001
Morphology 3 5.82 0.12 4.95 0.18 8.77 0.03
Familial risk category 2 18.9 o0.001 4.78 0.09 20.2 o0.001
Nevus category 3 24.6 o0.001 7.78 0.05 28.1 o0.001
Red phenotype 1 7.57 0.006 0.29 0.59 4.15 0.04
Skin color 2 8.10 0.017 3.10 0.22 8.92 0.012
Skin type 3 11.9 0.008 4.72 0.19 11.5 0.009
Tanning ability 3 9.79 0.020 7.09 0.07 10.5 0.015
Solar keratoses 1 10.9 0.002 0.01 0.97 6.15 0.013
Skin cancers 1 7.69 0.006 3.34 0.07 12.9 o0.001
Behavior
(in situ vs invasive) 1 3.76 0.053 0.32 0.57 3.36 0.070
Freckling category 2 13.7 0.001 0.41 0.81 4.12 0.13
Anatomic site 5 5.80 0.33 1.09 0.95 5.29 0.38
Clark level 4 3.76 0.44 1.69 0.80 1.25 0.87
Sunburns 3 0.77 0.86 0.85 0.84 1.82 0.61
Hair color 5 2.46 0.79 2.07 0.84 1.91 0.86
Eye color 2 1.25 0.53 0.51 0.78 0.18 0.91
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strata of familial risk group (highþ intermediate; low); there
was some suggestion that risk group membership may be
a modifying factor, but the differences are likely to be due
to chance.
DISCUSSION
We have identified a number of characteristics that are
associated with significantly elevated risk of developing a
second primary melanoma. The strongest predictor was the
number of melanocytic nevi self-reported at baseline;
patients reporting large numbers of nevi had 3-fold higher
risks of developing a subsequent melanoma than those
reporting only small numbers of nevi. Other factors asso-
ciated with significantly elevated risks of second primary
melanomas included having a high familial risk of melano-
ma, a sun-sensitive skin type, and a melanoma of nodular or
lentigo maligna subtypes. Of note, about half of participants
with four or more primary melanomas were from the low
familial risk group, the clinical implication being that patients
with no or weak family history of melanoma may still be at
risk of multiple primary melanomas.
There are few studies with which to compare our findings.
Although some earlier studies have explored the inci-
dence and determinants of second primary melanoma in
large populations using record linkage techniques (Giles
et al., 1995; Goggins and Tsao, 2003; Levi et al., 2005;
McCaul et al., 2008), such investigations have been limited
to using routinely collected data and thus have been
constrained by the absence of data relating to the phenotype
of the patient. A larger number of studies have reported
the occurrence of multiple primary melanomas arising in
historical cohorts of patients treated at single institutions
(Ariyan et al., 1995; Johnson et al., 1998; Savoia et al., 1998;
DiFronzo et al., 1999; Ferrone et al., 2005). Such studies
typically have rich information describing histopathological
characteristics of the tumors, but phenotypic data relating to
the patient have seldom been collected in a systematic
manner. Three epidemiological studies of multiple primary
melanomas have been reported, and each gathered systema-
tic data on phenotype and family history of melanoma
(Burden et al., 1999; Begg et al., 2006; Titus-Ernstoff et al.,
2006). The Scottish Melanoma Group compared the charac-
teristics of patients with multiple versus single primary
melanomas, and found strong associations with high nevus
counts, family history of melanoma, and ‘‘nonuse of
sunscreen’’ (Burden et al., 1999). The study also reported a
high prevalence of germ-line CDKN2A mutations among
patients with multiple primary melanomas. The GEM study
used a to our knowledge, previously unreported design
comparing 1,210 patients with incident multiple primaries to
2,470 patients with a single primary melanoma (Begg et al.,
2006). That study also reported similar findings to ours; in
particular, that patients with high nevus counts were almost
3-fold more likely than those with low nevus counts to
Table 5. Hazard ratios and 95% CIs of time to first subsequent primary melanoma, in toto and within strata of
familial risk group
All participants High+intermediate familial risk strata Low familial risk stratum
Factor Category Hazard ratio1 (95% CI) Hazard ratio1 (95% CI) Hazard ratio1 (95% CI)
Sex Female 1.00 (ref) 1.00 (ref) 1.00 (ref)
Male 1.49 (1.12–2.00) 2.49 (1.47–4.23) 1.17 (0.81–1.68)
Histological type SSM, unspecified 1.00 (ref) 1.00 (ref) 1.00 (ref)
LMM 1.80 (1.05–3.07) 1.81 (0.74–4.43) 1.47 (0.70–3.10)
Nodular 2.13 (1.21–3.74) 1.10 (0.38–3.17) 2.63 (1.35–5.15)
Behavior Invasive 1.00 (ref) 1.00 (ref) 1.00 (ref)
In situ 1.36 (0.99–1.87) 1.38 (0.77–2.44) 1.30 (0.87–1.95)
Nevus count None or few 1.00 (ref) 1.00 (ref) 1.00 (ref)
Moderate 1.92 (1.40–2.65) 2.46 (1.41–4.29) 1.63 (1.08–2.47)
High 2.91 (1.94–4.35) 2.81 (1.35–5.85) 2.98 (1.82–4.89)
Tanning ability Able to tan 1.00 (ref) 1.00 (ref) 1.00 (ref)
Unable to tan 1.66 (1.13–2.43) 1.79 (0.88–3.61) 1.77 (1.11–2.83)
Skin color Dark/medium 1.00 (ref) 1.00 (ref) 1.00 (ref)
Fair or pale 1.51 (1.06–2.16) 2.22 (1.09–4.53) 1.33 (0.87–2.04)
Familial risk Low/intermediate 1.00 (ref) NA NA
High 2.12 (1.34 – 3.36)
Abbreviations: CI, confidence interval; LMM, lentigo maligna melanoma; NA, not applicable; SSM, superficial spreading melanoma.
1Hazard ratio and 95% CI derived by Cox’s proportional hazards regression in four strata of age, adjusted for all factors in the table.
Synchronous melanomas excluded.
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develop multiple primaries. The investigators also reported
positive associations with family history of melanoma,
freckling in childhood, and light hair color. Similar to the
Scottish group, the GEM investigators found a strong and
statistically significant 4-fold increased relative risk of multi-
ple primary melanoma associated with the mutations in
CDKN2A (Berwick et al., 2006). The New Hampshire
epidemiological study followed-up 354 cases from a case–-
control study, 27 of whom developed a subsequent primary
within 2 years (Titus-Ernstoff et al., 2006). Although limited in
statistical power, this study reported a strong positive
association with atypical nevi, and observed an inverse
association between lifetime sunburns and risk of second
primary melanoma.
Although we found some evidence of an association
between the anatomical sites of the first and second
melanomas, the concordance within specific sites was
modest, with a k value of only 0.21. A large, registry-based
study in Australia reported k statistics for body site
concordance 0.41 for synchronous melanomas and 0.29 for
metachronous lesions (Giles et al., 1995). Other studies have
also reported that anatomical concordance between first and
second primary melanomas exceeds that expected by
chance, but falls far short of a strong relationship (Johnson
et al., 1998).
Strengths of this study include the large sample, prospec-
tive design, and the systematic collection of phenotypic and
family history data at baseline. In addition, study participants
were followed-up through self-report and linkage to popula-
tion registers; the latter ensuring close to complete ascertain-
ment of subsequent melanomas. Thus our study is likely to
have high internal validity. We used standard measures for
assessing phenotype, which we have previously demon-
strated to possess moderate to high levels of repeatability
(Baxter et al., 2008). Moreover, as all such measures were
collected before outcomes, misclassification of these expo-
sures must have been nondifferential regarding outcome and
any resulting bias would likely be toward the null.
A potential limitation of this study was the fact that the
study sample was not representative of the population of
people having a first primary melanoma. This occurred for
two reasons. First, the parent study (QFMP) was designed to
identify genetic factors associated with melanoma develop-
ment and thus intentionally oversampled patients from
families with higher than average risk of developing a
primary cutaneous melanoma (Aitken et al., 1996). Second,
we were required to obtain new consent from study partici-
pants in 2003–2005 to enable linkage to the cancer registry
that necessarily restricted the cohort to those who were alive
and contactable at that time. Supplementary analyses showed
significant differences in age and tumor characteristics
between those QFMP participants who were followed up
with those who were not, and thus the cumulative risk of
developing a second melanoma in this cohort was higher
(13% at 10 years) than has been reported previously in the
Queensland population (6.4%) (McCaul et al., 2008). For
these reasons, our findings about the incidence of second
primary melanoma may not be generalizable to other
populations. However, we have no reason to believe that
the associations we observed between patient characteristics
and the risk of developing a second primary melanoma
would be biased.
In conclusion, patients diagnosed with a first primary
melanoma have a high risk of developing a second primary
tumor, and the risks are highest for those with large numbers
of nevi or who have a higher than average family history of
melanoma. Other factors, including red hair phenotype and
fair skin, appear to modestly increase the risk of subsequent
melanoma. These factors can be assessed in all patients at the
time of diagnosis with a first primary melanoma; those at
highest risk for developing second melanomas can be
counseled appropriately.
MATERIALS AND METHODS
The analyses presented here were embedded within the QFMP, a
family-based study of melanoma patients for which the full details
have been described elsewhere (Aitken et al., 1996; Siskind et al.,
2002; Baxter et al., 2008). Briefly, the QFMP comprised a sample of
melanoma patients diagnosed with first primary cutaneous melano-
ma in Queensland between 1 January 1982 and 31 December 1990
and registered with the Queensland Cancer Registry (QCR; notifica-
tion of cancers became mandatory in Queensland in 1982).
Diagnoses had to be confirmed by histology, and could be in situ
or invasive. Patients with acral lentiginous melanoma were not
eligible for the QFMP. The QFMP intentionally oversampled patients
with a known family history of melanoma to facilitate future genetic
research; the algorithm used to stratify patients by family history is
described below. In total, 1,897 probands (i.e., patients meeting the
eligibility criteria above) completed a detailed, self-administered
questionnaire in 1991–1993 requesting information on family
history, risk factors, and medical and residential history.
A subsample of 1,083 QFMP probands was re-contacted between
2002 and 2005 to elicit further diagnoses of melanoma and
authorize a confirmatory search in the QCR (Baxter et al., 2008).
All participants gave their informed written consent to take part, and
the study was conducted according to the Declaration of Helsinki
Principles. The human research ethics committee of the Queensland
Institute of Medical Research approved all described studies.
Records were sought for all consenting respondents who reported
melanoma diagnosed in Queensland since 1982 (the first year of
mandatory cancer registration in that state). Where a respondent was
known by a name other than their legal name, or changed their
names, a record for each known alias was submitted to the QCR to
attempt to capture all possible records for an individual. For
completeness of records, information pertaining to all reported
cancers (not only melanomas) was requested.
Data were received from QCR in the form of a de-identified
electronic data file. Where a record could not be located at the QCR,
or diagnosis was reported in another state, a request was submitted
to a doctor nominated by the respondent (generally the diagnosing
doctor) for a copy of the histopathology reports. If the doctor did not
reply within 2 weeks, a telephone interviewer called the practice to
request a copy of information. Where the practice advised that the
doctor had died, moved, or sold the practice, the interviewer then
contacted the family of the doctor, the new practice owner, or
associated record management company in an attempt to locate the
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missing records. Where this was unsuccessful, an attempt was made
to locate the information through subsequent treating doctors
nominated by the respondent. Once received, the histopathology
reports were then coded by a QCR-trained medical coder using
International Classification of Diseases for Oncology (third edition)
and double-entered into a database.
Pathology reports were reexamined and corrected, and the file
correspondingly updated, in 2009. For each primary melanoma
diagnosed, trained study nurses abstracted salient details from the
pathology report including the date of diagnosis, anatomic site,
behavior (in situ or invasive), and Clark level or Breslow thickness.
Variables for analysis
All variables used in analyses were derived from the original
baseline questionnaire. Age was defined as age at diagnosis of the
first primary melanoma. Skin color, self-assessed on unexposed sites
such as the inner upper arm, was recorded in two categories (dark/
medium, fair), eye color in three categories (blue/gray, green/hazel,
and brown), and early adult hair color in six categories (fair/blonde,
light brown, light red/ginger, dark red/auburn, dark brown, and
black). Propensity to burn in the sun was categorized as never,
sometimes or always burn, and tanning ability after prolonged sun
exposure as none, slight, moderate, or deep tan. Self-reported nevus
density was recorded in four categories by comparison with
diagrammatic representations (none, few, moderate, or many) and
density of freckling in summer was categorized as none, p100
freckles or 4100. Number of sunburns during life was recorded as
none, 1, 2–5, or 45. Self-reported history of solar keratoses or
keratinocyte skin cancers (squamous cell carcinomas and basal cell
carcinomas) was also obtained.
We derived a ‘‘red phenotype’’ variable, defined as individuals
with red hair and/or more than 100 freckles. Participants were
further classified as belonging to high-, intermediate-, or low-risk
families according to a previously derived measure of familial
melanoma risk described in detail elsewhere (Aitken et al., 1994).
Briefly, this index was based on the number of cases of melanoma
among all relatives in the family in excess of those predicted from
the age-, sex- and birth cohort-specific cumulative incidences of
melanoma among all relatives in the sample. Participants in the top
2.5% of the cohort were placed in the high-risk category, those
between the median and the 97.5 percentile were assigned to the
intermediate category, and those below to the low-risk category.
Familial risk categories were determined at entry to the cohort.
High-risk individuals were oversampled for re-contact.
UV radiation exposure—total in childhood (5–12 years), adoles-
cence (13–19 years), and average per year from 20 years of age on—
was estimated from the lifetime residence and sun exposure
calendars were completed by the participants at baseline (Siskind
et al., 2002).
Data analysis
Our primary aim was to identify predictors of second primary
melanomas within the cohort. Our secondary aim was to describe
the distribution of second and subsequent melanomas, but general-
ization of the latter findings to other populations should be pursued
with caution given the selected nature of our cohort.
Second melanomas were deemed to be synchronous with the
index lesion if they were diagnosed within 30 days of the latter.
These were included in analyses of total numbers of lesions, but not
when time from first to the second histological diagnosis of primary
melanoma was the outcome measure. In comparisons of character-
istics of first (index) with second melanomas, persons with only
synchronous lesions have been excluded. In those with both
synchronous and metachronous lesions, the first melanoma occur-
ring more than 30 days after the index melanoma served as the
‘‘second’’ lesion in the above analyses.
Univariate analysis of numbers of subsequent melanomas was
performed using Kruskal–Wallis nonparametric tests for categorical
or ordinal factors. As a check failure-time analysis of time to first
subsequent metachronous melanoma, with log-rank tests, was also
used. For continuous factors (thickness, UV exposure) Kendall’s
nonparametric correlation coefficient (t) was used.
Multivariate analysis was by means of Cox proportional hazard
regression on time to first subsequent melanoma across four age
strata (o40, 40–49, 50–59, and X60 years). On the basis of the
results of the univariate analyses, levels in several of the phenotypic
variables were combined before inclusion in the proportional
hazards models. Phenotypic variables are highly intercorrelated;
the minimal included subset of this group of variables was
established by sequential elimination.
Apart from the entire file, men, and women were also analyzed
separately by univariate methods. In the multivariate analysis, sex is
included as a predictor.
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